Abstract:e15531 Background: Persistent inflammatory diseases such as ulcerative colitis (UC) and Crohn’s disease (CD) contribute to the tumor initiation and progression in colitis-associated cancers (CAC). Intestinal damage caused by persistent inflammation promotes clonal expansion of somatic and epithelial cells and alters the immune microenvironment. A comprehensive investigation in comparing the tumor immune environment in CAC with sporadic colorectal cancers (CRC) will provide more clinical usefulness of immunoprofiling in CRC. Methods: Thirteen patients with CAC (6 with UC and 7 with CD) and 10 patients with sporadic colorectal cancer from our hospital were enrolled in the study. FFPE samples from patients were analyzed for the tumor infiltrating lymphocytes [PD-L1+, CD3+, CD4+, CD8+, CD20+, CD68+, CD163+] by multiplex immunofluorescence technique. The core and peritumor areas annotated by pathologists on images. Then artificial intelligence (AI) algorithms delineated the tumor-enriched segments and stroma, and calculated the density and percentage of each marker in two regions. A nonparametric approach (Kruskal–Wallis) was used to compare the density and percentage of immune cells between CAC and sporadic colorectal cancer groups. Results: In the stroma area, the density (counts per mm 2 ) of PD-L1+CD68+ cells in patients with CAC were significantly higher than those in sporadic cancer patients (p < 0.05). However, the density of PD-L1+CD68+ did not show significant differences related to disease types (CAC or sporadic CRC) in the tumor-enriched segments. Significantly, the density of CD3+CD4+ cells and the percentage of CD68+CD163- cells in patients with CAC showed a trend of higher density than those in sporadic cancer patients in the stroma area (all, 0.05 < p < 0.1). The density and the percentage of CD20+ cells in CAC patients had a higher density tendency than those in sporadic cancer patients both in the tumor-enriched segments and stroma (all, 0.05 < p < 0.1). Other indicators in tumor-enriched segments and stroma, such as CD3+, CD4+, CD8+, CD68+CD163+ and PD-L1+, had no significant difference between CAC and sporadic CRC patients, regardless of the percentage or the density. Conclusions: We identified that the tumor immune environment of CAC was different from that of sporadic CRC. Some tumor infiltrating lymphocytes such as PD-L1+CD68+ cells infiltrated more in CAC than those in sporadic cancer, suggesting that CAC may respond better to immunotherapy than sporadic CRC. However, this hypothesis requires a further validation with a larger sample size.

Expression of low density lipoprotein receptor-related protein(LRP)-5 and LRP-6 in ulcerative colitis-associated cancer

Expression and Significance of Stem Cell Marker LGR5 Proteins in the Development and Progression of Human Colorectal Carcinoma

Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Tumor immune environment in colitis-associated colorectal cancers: Comparison with sporadic colorectal cancers.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Leucine‐rich repeat‐containing G protein‐coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications

Identification of immune-associated genes for the diagnosis of ulcerative colitis-associated carcinogenesis via integrated bioinformatics analysis

Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia

Lgr5 and CD44 Expressions in Different Types of Intestinal Polyps and Colorectal Cancer

LCN2 as a Potential Diagnostic Biomarker for Ulcerative Colitis-Associated Carcinogenesis Related to Disease Duration

Clinical and Endoscopic Manifestation of Ulcerative Clitis Associated Colorectal Cancer

Intestinal Stem Cell Marker LGR5 Expression During Gastric Carcinogenesis

Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions

The significance of PD-1/PD-L1 imbalance in ulcerative colitis

ERCC6L is a Biomarker and Therapeutic Target for Non–small Cell Lung Adenocarcinoma

Overexpression of Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) is Associated with Worsened Prognosis and Decreased Cancer Immunity in Clear-Cell Renal Cell Carcinoma.

[Knock-down of long noncoding RNA H19 (lncRNA H19) promotes human colorectal cell autophagy and inhibits cell apoptosis induced by lipopolysaccharide]

Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies

Correlation between expression of human cathelicidin peptide LL-37 and colon inflammation in patients with ulcerative colitis

Expressions and clinical significance of varied membrae transport proteins in patients with early non-small cell lung cancer